image
Healthcare - Biotechnology - NASDAQ - US
$ 34.17
-9.34 %
$ 1.89 B
Market Cap
-15.05
P/E
BALANCE SHEET
482 M ASSETS
392.63%
29.1 M LIABILITIES
-86.36%
453 M EQUITY
493.40%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Structure Therapeutics Inc.
image
Current Assets 474 M
Cash & Short-Term Investments 467 M
Receivables 0
Other Current Assets 6.28 M
Non-Current Assets 8.41 M
Long-Term Investments 0
PP&E 8.36 M
Other Non-Current Assets 45 K
Current Liabilities 24.7 M
Accounts Payable 4.74 M
Short-Term Debt 2.88 M
Other Current Liabilities 17.1 M
Non-Current Liabilities 4.31 M
Long-Term Debt 4.01 M
Other Non-Current Liabilities 298 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 129.8 90.8 0.1 16.4 K
Short Term Investments 337.5 64.8 2 K 21.1 K
Receivables 0 0 0 0
Inventory 0 0 0 0
Other Current Assets 6.3 2.2 1.9 1.0
Total Current Assets 473.6 93.1 0.1 38.4 K
PP&E 8.4 1.3 1.79 K 277
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 0 0 0 0
Other Long Term Assets 45 K 3.5 111 8
Other Assets 0 0 0 0
Total Assets 482.0 97.8 0.1 38.7 K
LIABILITIES
Accounts Payable 4.7 6.0 3.5 1.5
Short Term Debt 2.9 0.5 0.3 0.1
Other Current Liabilities 16.8 6.3 (3.8) (1.7)
Total Current Liabilities 24.7 13.0 8.66 K 3.04 K
Long Term Debt 4.0 0 0.3 0.1
Deferred Tax Income 0 0 0 0
Other Liabilities 0.3 0 (0.1) 74.9 K
Total Liabilities 29.1 213.0 0.2 61.2 K
EQUITY
Common Stock 14 K 1 K 1 1
Retained Earnings (206.6) (117.0) 64.7 K 22.9 K
Other Accumulative Comprehensive Income/Loss 0.5 (0.1) (167.0) 1
Total Equity 453.0 (115.1) 64.7 K 22.5 K
Total Liabilities and Equity 482.0 97.8 0.1 38.7 K
SHARES OUTSTANDING
Common Shares Outstanding 36.7 36.6 36.6 36.6